X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4%
Thu, 24 Jan

INDOCO REMEDIES has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m2,7812,3562,62611.4%-5.6%
Other incomeRs m63672.7%3.6%
TurnoverRs m2,7872,3602,63111.5%-5.6%
ExpensesRs m2,3492,2382,3786.2%1.2%
Gross profitRs m432118248109.8%-42.7%
DepreciationRs m1731771770.5%2.5%
InterestRs m215037-25.7%75.5%
Profit before taxRs m243-10539-84.0%
TaxRs m17-27-14-185.7%
Profit after taxRs m227-7853-76.4%
Gross profit margin%15.55.09.4
Effective tax rate%6.926.0-36.9
Net profit margin%8.1-3.32.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 5.6% on a year-on-year (YoY) basis. The expenses were up by 1.2% YoY during the same period.
  • The company's operating profit declined by 42.7% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 9.4% in 3QFY19 as against 15.5% in 3QFY18.
  • Depreciation charges increased by 2.5% and finance costs increased by 75.5% YoY, respectively.
  • Other income increased by 3.6% YoY during the quarter.
  • Net profit for the quarter declined by 76.4% YoY. Net profit margins during the quarter declined from 8.1% in 3QFY18 to 2.0% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 6.2% QoQ during the same period.
  • The company's operating profit increased by 109.8% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 9.4% in 3QFY19 as against 5.0% in 2QFY18.
  • Net profit for the quarter increased by 168.5% QoQ, while net profit margins increased from -3.3% in 2QFY18 to 2.0% in 3QFY19.

To see how INDOCO REMEDIES has performed over the last eight quarters, please visit here.

INDOCO REMEDIES Share Price Performance

Over the last one year, INDOCO REMEDIES share price has moved up from Rs 298.1 to Rs 200.6, registering a Loss of Rs 97.5 or around 32.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,090.6 (up 0.2%). Over the last one year it has moved down from 15,142.6 to 14,090.6, a gain of 1,052 points (down 6.9%).

Overall, the S&P BSE SENSEX is up 0.2% over the year.

Current Valuations

At the current price of Rs 200.6, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 306.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.8 times.

Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4%". Click here!

  

Related Views on News

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 139.4% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, INDOCO REMEDIES has posted a net profit of Rs 78 m (down 139.4% YoY). Sales on the other hand came in at Rs 2 bn (down 17.3% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY18); Net Profit Up 14.3% (Quarterly Result Update)

Jun 19, 2018 | Updated on Jun 19, 2018

For the quarter ended March 2018, INDOCO REMEDIES has posted a net profit of Rs 205 m (up 14.3% YoY). Sales on the other hand came in at Rs 3 bn (down 2.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These Dividend Stocks Could Boost Your Returns Better Than You Can Imagine(Profit Hunter)

May 7, 2019

The art of dividend investing is a lot more than investing in companies with high dividend payouts or stocks with high dividend yields...

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

A 10-Bagger in Just 6 Years! The Rebirth of India Will Create More Big Winners Like This(The 5 Minute Wrapup)

May 7, 2019

How a niche tech startup battled all odds to eventually become a 10 bagger.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


May 20, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - CCL INTERNATIONAL COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS